Table 2.
Number of women mentioning each major and subtheme overall and by test result group
| Overall | HPV negative | HPV positive, cytology normal | HPV positive, cytology abnormal | Persistent HPV | Cleared HPV | χ2(df), p value |
|
| (n=381) | (n=65) | (n=129) | (n=67) | (n=91) | (n=29) | ||
| n (%) | n (%) | n (%) | n (%) | n (%) | n (%) | ||
| Reaction to and understanding of results | 170 (45) | 11 (17) | 69 (54) | 34 (51) | 39 (43) | 17 (59) | χ2(4)=27.72, 0.001 |
| Emotional response | 85 (22) | 5 (8) | 28 (22) | 24 (36) | 18 (20) | 10 (35) | |
| Meaning of results | 72 (19) | 1 (2) | 35 (27) | 11 (16) | 21 (23) | 4 (14) | |
| Impact on sexual relationships | 41 (11) | 0 | 25 (19) | 4 (6) | 11 (12) | 1 (3) | |
| Confidence in results | 20 (5) | 8 (12) | 4 (3) | 1 (2) | 1 (1) | 6 (21) | |
| Questions about HPV | 143 (38) | 8 (12) | 67 (52) | 20 (30) | 37 (41) | 11 (38) | χ2(4)=31.13, <0.001 |
| General lack of understanding | 24 (7) | 2 (3) | 15 (12) | 6 (9) | 4 (4) | 0 | |
| Epidemiology of HPV | 63 (17) | 2 (3) | 30 (23) | 5 (8) | 20 (22) | 6 (21) | |
| Cause of HPV | 32 (8) | 1 (2) | 20 (16) | 3 (5) | 6 (7) | 2 (7) | |
| Prevention/treatment of HPV | 28 (7) | 0 | 11 (9) | 7 (10) | 9 (10) | 1 (3) | |
| HPV vaccination | 39 (10) | 3 (5) | 20 (16) | 2 (3) | 11 (12) | 3 (10) | |
| Questions about cervical cancer | 52 (14) | 5 (8) | 24 (19) | 7 (10) | 14 (15) | 2 (7) | χ2(4)=6.58, 0.160 |
| Risk of cervical cancer | 45 (12) | 3 (3) | 20 (16) | 7 (10) | 14 (15) | 2 (7) | |
| Other cervical cancer risk factors | 14 (4) | 3 (5) | 7 (5) | 1 (2) | 2 (2) | 1 (3) | |
| Purpose and procedure for HPV testing | 85 (22) | 26 (40) | 20 (16) | 16 (24) | 16 (18) | 7 (24) | χ2(4)=16.51, 0.002 |
| Purpose | 22 (6) | 11 (17) | 5 (4) | 4 (6) | 2 (2) | 0 | |
| Procedure | 18 (5) | 10 (15) | 3 (2) | 1 (2) | 0 | 4 (14) | |
| Timing | 36 (9) | 4 (6) | 12 (9) | 5 (8) | 11 (12) | 4 (14) | |
| Delivery of results | 15 (4) | 4 (6) | 1 (1) | 7 (10) | 3 (3) | 0 | |
| Future implications of test results | 73 (19) | 1 (2) | 30 (23) | 10 (15) | 27 (30) | 5 (17) | χ2(4)=21.76, <0.001 |
| Clinical management | 39 (10) | 1 (2) | 14(11) | 4 (6) | 19 (21) | 1 (4) | |
| Fertility/sexual health | 13 (3) | 0 | 5 (4) | 1 (3) | 3 (3) | 3 (10) | |
| Advice on clearing HPV | 18 (5) | 0 | 10 (8) | 2 (3) | 5 (6) | 1 (3) | |
| Testing for partners | 7 (2) | 0 | 4 (3) | 2 (3) | 1 (1) | 0 | |
| Information seeking/(di)satisfaction | 85 (22) | 8 (12) | 37 (29) | 14 (21) | 22 (24) | 4 (14) | χ2(4)=8.25, 0.083 |
| Information seeking | 30 (8) | 3 (5) | 15 (12) | 7 (10) | 5 (6) | 0 | |
| (Di)satisfaction | 73 (19) | 6 (9) | 31 (24) | 12 (18) | 20 (22) | 4 (14) |
HPV, human papillomavirus.